PLUS THERAPEUTICS, INC. — Director's Dealing 2010

Dec 23, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-12-22

Reporting Person: CALHOUN CHRISTOPHER J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-22	Common Stock	S	200	$5.59	Disposed	131050	Direct
2010-12-22	Common Stock	S	5700	$5.6	Disposed	125350	Direct
2010-12-22	Common Stock	S	2373	$5.61	Disposed	122977	Direct
2010-12-22	Common stock	S	500	$5.62	Disposed	122477	Direct
2010-12-22	Common stock	S	3145	$5.63	Disposed	119332	Direct
2010-12-22	Common stock	S	1026	$5.64	Disposed	118306	Direct
2010-12-22	Common stock	S	2800	$5.65	Disposed	115506	Direct
2010-12-22	Common stock	S	3039	$5.66	Disposed	112467	Direct
2010-12-22	Common stock	S	4200	$5.67	Disposed	108267	Direct
2010-12-22	Common stock	S	4600	$5.68	Disposed	103667	Direct
2010-12-22	Common stock	S	1212	$5.69	Disposed	102455	Direct
2010-12-22	Common stock	S	4255	$5.70	Disposed	98200	Direct
2010-12-22	Common stock	S	362	$5.71	Disposed	97838	Direct
2010-12-22	Common stock	S	1200	$5.72	Disposed	96638	Direct
2010-12-22	Common stock	S	3100	$5.75	Disposed	93538	Direct
2010-12-22	Common stock	S	2813	$5.76	Disposed	90725	Direct
2010-12-22	Common stock	S	700	$5.77	Disposed	90025	Direct
2010-12-22	Common stock	S	600	$5.8	Disposed	89425	Direct
2010-12-22	Common stock	S	1000	$5.81	Disposed	88425	Direct
2010-12-22	Common stock	S	4700	$5.82	Disposed	83725	Direct
2010-12-22	Common stock	S	500	$5.83	Disposed	83225	Direct
2010-12-22	Common stock	S	100	$5.86	Disposed	83125	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36850	Indirect

Footnotes

F1: Shares sold pursuant to a 10b5-1 Plan.